Bailey Lynn B, Duhaney Robert L, Maneval David R, Kauwell Gail P A, Quinlivan Eoin P, Davis Steven R, Cuadras Aisha, Hutson Alan D, Gregory Jesse F
Food Science and Human Nutrition Department, and. Department of Statistics, University of Florida, Gainesville 32611, USA.
J Nutr. 2002 Jul;132(7):1872-8. doi: 10.1093/jn/132.7.1872.
Methylenetetrahydrofolate reductase (MTHFR) polymorphisms may negatively influence one-carbon metabolism and increase health risks in women of reproductive age. The effect of MTHFR single nucleotide polymorphisms at bp 677 and/or 1298 and differences in folate and vitamin B-12 status on plasma homocysteine concentration in women of reproductive age (20-30 y; n = 186) were investigated. From the multivariate regression model, homozygotes (n = 23) for the C677T MTHFR variant had plasma homocysteine concentrations that were higher (P < 0.05) than those observed in the other 5 genotype groups, including those who were heterozygous for both variants (677CT/1298AC; n = 32). Plasma homocysteine was negatively associated with plasma vitamin B-12 concentration (P = 0.015) and serum folate (P = 0.049), with the degree of correlation between plasma vitamin B-12 and homocysteine concentrations dependent on MTHFR genotype. The C677T and A1298C MTHFR polymorphisms were significant predictors (P < 0.05) of plasma homocysteine when regression analysis was used to model plasma homocysteine concentration as a function of genotype, supplement use, serum folate and plasma vitamin B-12 concentration. Plasma homocysteine decreased as vitamin B-12 concentration increased (P = 0.0005) in individuals who were heterozygous for both the C677T and A1298C variants with nonsignificant trends (P = 0.114-0.128) in individuals homozygous for either the C677T or A1298C variants. In contrast, within the group of individuals with the wild-type genotype for both the C677T and A1298C MTHFR variants, homocysteine was not associated with changes in plasma vitamin B-12 concentrations. These data suggest that enhancing vitamin B-12 status may significantly decrease homocysteine in young women with C677T and/or A1298C MTHFR polymorphisms, even when vitamin B-12 concentrations are within the normal range.
亚甲基四氢叶酸还原酶(MTHFR)基因多态性可能对一碳代谢产生负面影响,并增加育龄妇女的健康风险。本研究调查了MTHFR基因677位和/或1298位单核苷酸多态性以及叶酸和维生素B-12状态差异对186名育龄妇女(20 - 30岁)血浆同型半胱氨酸浓度的影响。多元回归模型显示,C677T MTHFR变异纯合子(n = 23)的血浆同型半胱氨酸浓度高于其他5种基因型组(P < 0.05),包括两种变异均为杂合子的个体(677CT/1298AC;n = 32)。血浆同型半胱氨酸与血浆维生素B-12浓度(P = 0.015)和血清叶酸(P = 0.049)呈负相关,血浆维生素B-12与同型半胱氨酸浓度之间的相关程度取决于MTHFR基因型。当使用回归分析将血浆同型半胱氨酸浓度作为基因型、补充剂使用、血清叶酸和血浆维生素B-12浓度的函数进行建模时,C677T和A1298C MTHFR基因多态性是血浆同型半胱氨酸的显著预测因子(P < 0.05)。对于C677T和A1298C变异均为杂合子的个体,血浆同型半胱氨酸随维生素B-12浓度升高而降低(P = 0.0005),而对于C677T或A1298C变异纯合子个体,变化趋势不显著(P = 0.114 - 0.128)。相反,在C677T和A1298C MTHFR变异均为野生型基因型的个体组中,同型半胱氨酸与血浆维生素B-12浓度变化无关。这些数据表明,即使维生素B-12浓度在正常范围内,提高维生素B-12水平也可能显著降低具有C677T和/或A1298C MTHFR基因多态性的年轻女性的同型半胱氨酸水平。